Literature DB >> 12394330

Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic variables in plasma--a 2-year follow-up study.

Torbjörn K Nilsson1, J David Spence, Peter M Nilsson, Mats Eliasson, Jan-Håkan Jansson, Kurt Boman.   

Abstract

BACKGROUND: It has been proposed that the mechanism of action of the new risk factors for myocardial infarction and stroke, von Willebrand factor (vWF), tissue plasminogen activator (tPA) and tissue plasminogen activator inhibitor-1 (PAI-1) could possibly be mediated via a primary effect on atherogenesis but there is little data to substantiate this.
DESIGN: A prospective single-centre cohort study of progression of atherosclerosis.
METHODS: Carotid plaque area was quantitated by two-dimensional (2D) ultrasound in 258 subjects at entry and after 1 and 2 years. Plasma and serum samples were drawn at baseline and serum lipids and plasma levels of haemostatic factors were measured.
RESULTS: The traditional risk factors, smoking, total cholesterol, hypertension and male gender explained 51% of the variance in plaque area at baseline and 48% at 1-year follow-up. There were small positive associations of plaque area with vWF, tPA and tPA/PAI-1 complex and a tendency to negative associations with PAI-1 levels, independent from the traditional risk factors. The additional explanatory power of the haemostatic factors did not exceed 3%.
CONCLUSION: The data accord with a marginal role in atherogenesis of vWF and tPA, and underline the major impact of smoking, hypertension and cholesterol on carotid plaque area progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394330     DOI: 10.1177/174182670200900406

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  3 in total

1.  Association between variations in coagulation system genes and carotid plaque.

Authors:  David Della-Morte; Ashley Beecham; Chuanhui Dong; Liyong Wang; Mark S McClendon; Hannah Gardener; Susan H Blanton; Ralph L Sacco; Tatjana Rundek
Journal:  J Neurol Sci       Date:  2012-09-13       Impact factor: 3.181

Review 2.  Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence.

Authors:  Nina Buchtele; Michael Schwameis; James C Gilbert; Christian Schörgenhofer; Bernd Jilma
Journal:  Thromb Haemost       Date:  2018-05-30       Impact factor: 5.249

3.  Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.

Authors:  Peter Kraft; Christiane Drechsler; Ignaz Gunreben; Bernhard Nieswandt; Guido Stoll; Peter Ulrich Heuschmann; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.